VitaPep field notes · 01

The science of the compounds.

Peptides are small by design. Their effects, their evidence, and their limits are not. Here is the molecular map behind five names you may see on a label—and the research context that should come with each one.

Research guideUpdated September 2026Read time · 8 min

01 · How to read the science

Start with the structure. End with the evidence.

A peptide is a chain of amino acids. Change the sequence, its shape, or what it is bound to, and you change the biological conversation. That is why GHK-Cu is not simply “GHK,” why TB-500 is not the same as thymosin beta-4, and why a lab finding cannot be copied from one compound to another.

The profiles below separate three things often blurred together: what a molecule is, what researchers have observed, and what a finished topical product can responsibly say. Much of the literature is cellular or preclinical. That makes it useful for understanding mechanism—but not a substitute for human clinical evidence, product directions, or medical advice.

02 · The molecule desk

Five compounds. Five different stories.

Sequence length is not a scorecard. It is a clue to chemistry, stability, and the kinds of biological questions researchers can ask.

Gly-His-Lys · Cu²⁺GHK-CuA copper peptide in cosmetic researchGEPPPGKPADDAGLV · 15 aaBPC-157A peptide studied largely in preclinical models Ac-LKKTETQ · 7 aaTB-500An acetylated thymosin beta-4 fragment Lys-Pro-Val · 3 aaKPVA short melanocortin-derived sequence Bremelanotide · cyclic heptapeptidePT-141A melanocortin-receptor research compound

Compound profile

GHK-Cu

A copper peptide in cosmetic research

GHK is a naturally occurring three-amino-acid peptide—glycine, histidine, and lysine—that can bind copper ions. In cell and skin research, GHK-Cu has been associated with collagen and glycosaminoglycan production, fibroblast activity, and tissue-remodeling signals.

Research interestResearch interest centers on skin quality: elasticity, firmness, texture, and the visible effects of photoaging.

Read the fine printThe strongest story is mechanistic and cosmetic—not a promise to heal an injury or treat disease.

Primary reading · Fibroblast collagen study Read the GHK-Cu evidence guide View GHK-Cu product details

IdentityGly-His-Lys · Cu²⁺

Compound profile

BPC-157

A peptide studied largely in preclinical models

BPC-157 is a synthetic pentadecapeptide originally described from gastric protein fractions. Preclinical work has explored its relationship to vascular signaling, nitric oxide pathways, angiogenesis, fibroblast activity, and inflammatory cytokines.

Research interestThe research conversation spans gastrointestinal integrity and musculoskeletal repair, especially in animal and cellular models.

Read the fine printHuman evidence and clinical safety data remain limited; preclinical promise is not the same as an approved therapy.

Primary reading · 2025 systematic review Read the BPC-157 evidence guide View BPC-157 product details

IdentityGEPPPGKPADDAGLV · 15 aa

Compound profile

TB-500

An acetylated thymosin beta-4 fragment

TB-500 is commonly described as an acetylated fragment related to thymosin beta-4. The sequence sits close to the actin-binding region of the larger protein, which is why research discussions often focus on cell migration, angiogenesis, and wound-repair biology.

Research interestStudies have examined re-epithelialization, collagen deposition, and cell movement in repair models.

Read the fine printThe parent fragment, its metabolites, and full-length thymosin beta-4 should not be treated as interchangeable molecules.

Primary reading · TB-500 metabolism study Read the TB-500 evidence guide View TB-500 product details

IdentityAc-LKKTETQ · 7 aa

Compound profile

KPV

A short melanocortin-derived sequence

KPV is a tripeptide fragment derived from alpha-melanocyte-stimulating hormone. Unlike a large receptor drug, this compact sequence has been studied for effects on inflammatory signaling, including NF-κB activity and chemokine release in epithelial-cell models.

Research interestResearch interest centers on cell signaling and experimental-delivery questions; a benefit from a comparable finished topical formula has not been established.

Read the fine printCell-culture findings help explain a mechanism; they do not establish topical efficacy across people or conditions.

Primary reading · KPV keratinocyte study Read the KPV evidence guide View KPV product details

IdentityLys-Pro-Val · 3 aa

Compound profile

PT-141

A melanocortin-receptor research compound

PT-141, also known as bremelanotide, is a cyclic peptide described as a melanocortin-receptor agonist. Its molecular story is receptor signaling rather than tissue repair, and route and finished-product format are essential when interpreting its evidence.

Research interestPublished controlled human research concerns a prescription subcutaneous formulation, not a comparable finished topical serum.

Read the fine printEvidence from a different formulation and administration route cannot establish equivalent absorption, safety, or effects for an external-use formula.

Primary reading · Phase III bremelanotide study Read the PT-141 evidence guide View PT-141 product details

IdentityBremelanotide · cyclic heptapeptide

03 · Evidence, not promises

Good science keeps its verbs honest.

Observed in a study“Increased” or “was associated with”

A measured result in a named model, under defined conditions.

Useful research context“May support” or “is being studied for”

A reasonable description of interest that does not promise an outcome.

Too far, too soon“Treats,” “cures,” or “guarantees”

Claims that require appropriate clinical evidence and regulatory context.

VitaPep formulas are presented according to their labels and directions for external cosmetic use. This guide is educational information, not medical advice, diagnosis, or a recommendation to use any compound to treat an ailment. Always review the exact product page and speak with a qualified clinician about health concerns.